3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Motor Activity
6
Breast Neoplasms
3
Neoplasms
2
Stomach Neoplasms
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurotoxicity Syndromes
1
Mouth Neoplasms
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
COVID-19
1
Interventions
pembrolizumab
88
Carboplatin
77
Specimen Handling
76
Magnetic Resonance Spectroscopy
63
Pemetrexed
59
Cisplatin
47
durvalumab
44
Paclitaxel
38
Nivolumab
34
atezolizumab
32
osimertinib
29
Radiotherapy
29
Radiosurgery
29
Biopsy
26
Blood Specimen Collection
25
Gemcitabine
24
Docetaxel
24
Immunoglobulin G
23
Disulfides
22
Standard of Care
21
Drug Therapy
21
Etoposide
19
Taxes
18
Practice Guidelines as Topic
18
Radiation
17
Educational Status
16
130-nm albumin-bound paclitaxel
15
X-Rays
14
Surveys and Questionnaires
14
Bevacizumab
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Nutritional Status
×
1 year
×
Clear all
NCT07042724
2025-06-29
STARLighT
Universita di Verona
Phase NA
Recruiting
324 enrolled